Currently, there are no antivirals licensed by the FDA to treat patients with COVID-19.
The FDA has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with coronavirus disease 2019 (COVID-19).
The FDA has announced that it will not object to the New York State Department of Health (NYSDOH) authorizing certain laboratories in New York to start testing patients for coronavirus disease 2019 (COVID-19) once the tests have been validated.
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has released an updated version of the child and adolescent immunization schedule for ages 18 years and younger in the United States.
A recent report published in the New England Journal of Medicine describes the case of a patient with persistent skin discoloration associated with the use of the antiarrhythmic agent amiodarone. The 81-year-old man presented to the emergency department after a fall, which was eventually attributed to orthostatic hypotension. His medical history included atrial fibrillation and…
An expert panel assessed 35 diets to come up with the final results, examining the evidence behind each diet’s claims.
In an effort to further address the current opioid crisis, the FDA contracted the NASEM to examine existing opioid prescribing guidelines and to help outline the type of research needed to fill the gaps in evidence.
The FDA has approved Ervebo (Ebola Zaire vaccine, live) for the prevention of disease caused by Zaire ebolavirus in individuals ≥18 years of age.
Black elderberry extract could potentially induce pancreatitis, as described in a recent case report published in the journal Digestive Diseases and Sciences.
An intermittent fasting diet may be beneficial for reducing body mass index (BMI) and improving glycemic control, according to a recent systematic review and meta-analysis published in the Journal of Clinical Medicine.
